have been identified in various malignancies, and activate the PI3K/AKT/mTOR and RAS/RAF/MEK pathways, respectively. Both pathways are critical drivers of tumorigenesis. mutations using polymerase chain reaction-based DNA sequencing. (p = 0.001). mutations
Molecular profiling with next generation sequencing (NGS) delivers key information on mutant gene se...
The phosphatidylinositol 3-kinases-AKT-mammalian target of rapamycin pathway (PI3K/AKT/mTOR) is cent...
Phosphoinositide-3-kinase catalytic alpha polypeptide (PIK3CA) encodes the p110a subunit of the mito...
have been identified in various malignancies, and activate the PI3K/AKT/mTOR and RAS/RAF/MEK pathwa...
Genomic findings underscore the heterogeneity of head and neck squamous cell carcinoma (HNSCC). Iden...
Genomic findings underscore the heterogeneity of head and neck squamous cell carcinoma (HNSCC). Iden...
Oncogenic mutations of PIK3CA, RAS (KRAS, NRAS), and BRAF have been identified in various malignanci...
Molecular alterations involving the PI3K/AKT/mTOR pathway (including mutation, copy number, protein,...
PIK3CA mutations are frequently diagnosed in diverse cancers and may predict response to PI3K/AKT/mT...
AbstractIt is now widely accepted that cancer is a genetic disease and that alterations in the DNA s...
The RAS/MAP kinase and the RAS/PI3K/AKT pathways play a key role in the regulation of proliferation,...
Oncogenic PIK3CA mutations contribute to colorectal tumorigenesis by activating AKT signaling to dec...
ABSTRACT Genes encoding components of the PI3K–AKT–mTOR signaling axis are frequently mutated in can...
Constitutive activation of the phosphatidylinositol-3-OH kinase (PI3K) and RAS signaling pathways ar...
The Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades are often activated by genetic alterations in up...
Molecular profiling with next generation sequencing (NGS) delivers key information on mutant gene se...
The phosphatidylinositol 3-kinases-AKT-mammalian target of rapamycin pathway (PI3K/AKT/mTOR) is cent...
Phosphoinositide-3-kinase catalytic alpha polypeptide (PIK3CA) encodes the p110a subunit of the mito...
have been identified in various malignancies, and activate the PI3K/AKT/mTOR and RAS/RAF/MEK pathwa...
Genomic findings underscore the heterogeneity of head and neck squamous cell carcinoma (HNSCC). Iden...
Genomic findings underscore the heterogeneity of head and neck squamous cell carcinoma (HNSCC). Iden...
Oncogenic mutations of PIK3CA, RAS (KRAS, NRAS), and BRAF have been identified in various malignanci...
Molecular alterations involving the PI3K/AKT/mTOR pathway (including mutation, copy number, protein,...
PIK3CA mutations are frequently diagnosed in diverse cancers and may predict response to PI3K/AKT/mT...
AbstractIt is now widely accepted that cancer is a genetic disease and that alterations in the DNA s...
The RAS/MAP kinase and the RAS/PI3K/AKT pathways play a key role in the regulation of proliferation,...
Oncogenic PIK3CA mutations contribute to colorectal tumorigenesis by activating AKT signaling to dec...
ABSTRACT Genes encoding components of the PI3K–AKT–mTOR signaling axis are frequently mutated in can...
Constitutive activation of the phosphatidylinositol-3-OH kinase (PI3K) and RAS signaling pathways ar...
The Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades are often activated by genetic alterations in up...
Molecular profiling with next generation sequencing (NGS) delivers key information on mutant gene se...
The phosphatidylinositol 3-kinases-AKT-mammalian target of rapamycin pathway (PI3K/AKT/mTOR) is cent...
Phosphoinositide-3-kinase catalytic alpha polypeptide (PIK3CA) encodes the p110a subunit of the mito...
DOI
Add to ORKG